摘要
目的探讨急性心肌梗死患者应用主动脉内球囊反搏(IABP)治疗期间血小板减少的临床特点、处理及预后。方法入选我院2005年8月~2011年1月128例接受IABP治疗的急性心肌梗死患者,回顾性分析入选患者的血小板情况及临床特点。结果 128例患者应用IABP的时间为(86.4±7.1)h;应用IABP后有52例血小板减少患者,其中轻度减少者37例、重度减少者15例,无极重度患者;出现血小板减少的时间为开始IABP治疗后12h;停用IABP后有97.4%的患者血小板恢复至正常。结论急性心肌梗死患者应用IABP治疗时可出现明显的血小板减少,应该引起重视,在应用过程中应严密监测。
Objective To investigate the characteristics,treatment and prognosis of thrombocytopenia application intro-aortic balloon pump treating acute myocardial infarction patients.Methods From August 2005 to January 2011,we identified 128 acute myocardial infarction patients who accepted intro-aortic balloon pump treatment,and analyzed clinical characteristics of platelet retrospectively.Results Mean duration of intro-aortic balloon pump insertion of 128 acute myocardial infarction patients was(86.4±7.1) hours,52 patients have thrombocytopenia,37 patients with mild decreased platelet and 15 patients with severe decreased platelet;no extreme severe reduction condition;initial time of thrombocytopenia was 12 hours when intro-aortic balloon pump was used;platelet returned to normal of 97.4% patients when intro-aortic balloon pump was stopped.Conclusions Intro-aortic balloon pump treating acute myocardial infarction patients can induce thrombocytopenia.In order to reduce occurrence of condition,we should pay more attention and monitor strictly.
出处
《山东医药》
CAS
2012年第4期17-18,21,共3页
Shandong Medical Journal
关键词
心肌梗塞
主动脉内球囊反搏
血小板减少
acute myocardial infarction intro-aortic balloon pump thrombocytopenia